Literature DB >> 32520086

COVID-19 and benign intracranial hypertension: A case report.

Fabio Noro1, Fernando de Mendonça Cardoso2, Edson Marchiori1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32520086      PMCID: PMC7294953          DOI: 10.1590/0037-8682-0325-2020

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


× No keyword cloud information.
A 35-year-old female patient, without comorbidities, presented to the emergency room with fever, dyspnea, and adynamia over the previous four days. She also had a complaint of a headache that had started two days before admission. She was lucid and oriented, without focal neurological deficits. During hospitalization, the headache worsened and she became disoriented. Fundoscopy was impaired. A cerebrospinal fluid puncture was performed, showing increased pressure (40 cm H2O). The cerebrospinal fluid analysis was entirely normal and negative for several pathogens. Real-time reverse-transcription polymerase chain reaction testing of a nasopharyngeal swab confirmed SARS-Cov-2 infection. A brain magnetic resonance imaging scan showed signs of intracranial hypertension characterized by prominent subarachnoid space around optic nerves, vertical tortuosity of the optic nerves, and superior compression of the hypophysis (Figure 1A-C). Chest computed tomography showed round ground-glass opacities in both lungs (Figure 1D). The final diagnosis, based on clinical, laboratory, and imaging findings was benign intracranial hypertension (BIH).
FIGURE 1:

(A and B) T2 axial and coronal magnetic resonance imaging scan shows prominent subarachnoid space around the optic nerves and their vertical tortuosity (arrows); (C) Coronal T2 magnetic resonance imaging scan of the selar region demonstrates compression of the upper portion of the pituitary gland by the selar diaphragm (arrow). (D) Chest computed tomography shows round peripheral ground-glass opacities in the right lung (arrow).

The patient was treated with supportive measures and nasal oxygen. After two days of hospitalization, the patient returned to a normal level of consciousness and the headache disappeared. She was discharged asymptomatic two days later. BIH (pseudotumor cerebri) is a clinical condition that includes headache, papilledema, increased blood pressure, and clear cerebrospinal fluid1. Multiple causes have been described for this condition, including venous sinus thrombosis, the toxicity of some substances such as vitamin A, tetracyclines and contraceptives, and sepsis . To our knowledge, this is the first report of COVID-19 associated with isolated BIH.
  1 in total

1.  "Pseudotumor Cerebri" by any other name.

Authors:  J J Corbett
Journal:  Arch Ophthalmol       Date:  2000-12
  1 in total
  11 in total

1.  A wide spectrum of neurological manifestations in pediatrics patients with the COVID-19 infection: a case series.

Authors:  Mariana Braatz Krueger; Raquel Carvalho Montenegro; Pablo Picasso de Araújo Coimbra; Luanna de Queiroz Lemos; Regiane Martins Fiorenza; Carla Jéssica da Silva Fernandes; Mariana Santos Leite Pessoa; Cleonísio Leite Rodrigues; Camilla Gomes da Cruz; Verlene de Araújo Verdiano; Fernanda Montenegro de Carvalho Araújo; Pedro Braga-Neto; Manoel Alves Sobreira-Neto
Journal:  J Neurovirol       Date:  2021-08-26       Impact factor: 2.643

2.  Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Brianne N Sullivan; Tracy Fischer
Journal:  Front Aging Neurosci       Date:  2021-08-02       Impact factor: 5.750

3.  De Novo Presentation of Idiopathic Intracranial Hypertension (IIH) Associated With COVID-19 Infection.

Authors:  Saulius Sriuoginys; Sköld Margareta; Eliasson Jon Hersir
Journal:  Neurohospitalist       Date:  2022-05-18

Review 4.  Neuroradiologic Imaging of Neurologic and Neuro-Ophthalmic Complications of Coronavirus-19 Infection.

Authors:  Marcela Marsiglia; Bart K Chwalisz; Mary Maher
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 3.042

Review 5.  Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients.

Authors:  Prakash G Kulkarni; Amul Sakharkar; Tanushree Banerjee
Journal:  Hypertens Res       Date:  2021-11-30       Impact factor: 5.528

6.  The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?

Authors:  Rim Rakez; Wiem Boufrikha; Sana Lakhal; Amel Boughammoura; Mohamed Adnene Laatiri
Journal:  BMC Neurol       Date:  2022-05-02       Impact factor: 2.474

Review 7.  A Review on Headaches Due to COVID-19 Infection.

Authors:  Mansoureh Togha; Seyedeh Melika Hashemi; Nooshin Yamani; Fahimeh Martami; Zhale Salami
Journal:  Front Neurol       Date:  2022-07-12       Impact factor: 4.086

8.  Isolated intracranial hypertension associated with COVID-19.

Authors:  Marcus Tulius T Silva; Marco A Lima; Guilherme Torezani; Cristiane N Soares; Claudia Dantas; Carlos Otávio Brandão; Otávio Espíndola; Marilda M Siqueira; Abelardo Qc Araujo
Journal:  Cephalalgia       Date:  2020-11       Impact factor: 6.292

9.  Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review.

Authors:  Graziella Orrù; Ciro Conversano; Eleonora Malloggi; Francesca Francesconi; Rebecca Ciacchini; Angelo Gemignani
Journal:  Int J Environ Res Public Health       Date:  2020-09-14       Impact factor: 3.390

Review 10.  Neuro-Ophthalmologic Manifestations of Novel Coronavirus.

Authors:  Devin Betsch; Paul R Freund
Journal:  Adv Ophthalmol Optom       Date:  2021-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.